The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors.
暂无分享,去创建一个
R. Weichselbaum | A. Kozikowski | D. K. Bishop | Hillary L. Logan | P. Connell | Jennifer M O Mason | B. Budke | Michał Pawłowski | Megan Wu